Literature DB >> 4300189

The metabolic fate of vitamin D3-3H in chronic renal failure.

L V Avioli, S Birge, S W Lee, E Slatopolsky.   

Abstract

The absorption and metabolism of vitamin D(3)-(3)H was studied in eight patients with chronic renal failure. Although the intestinal absorption of vitamin D(3)-(3)H was normal, the metabolic fate of the vitamin was abnormal as characterized by a twofold increase in fractional turnover rate, an abnormal accumulation of biologically inactive lipid-soluble metabolites, and the urinary excretion of both vitamin D(3)-(3)H and biologically inactive metabolites. Neither alterations in water-soluble vitamin D(3) metabolites nor qualitative abnormalities in protein-binding of vitamin D(3) were observed in the uremic subjects. Although hemodialysis proved ineffectual in reversing the observed abnormalities in vitamin D(3) metabolism and excretion, renal homotransplantation was completely successful in this regard. These experiments support the conclusion that the resistance to therapeutic doses of vitamin D often seen in patients with chronic renal failure and renal osteodystrophy results from an acquired defect in the metabolism and excretion of vitamin D.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4300189      PMCID: PMC297388          DOI: 10.1172/JCI105909

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  [Glomerular hypocalciuria].

Authors:  A LICHTWITZ; R PARLIER; P HIOCO DBORDIER; P BORDIER
Journal:  Bull Mem Soc Med Hop Paris       Date:  1960 Jan 22-29

2.  Bone disease in chronic renal failure with particular reference to osteosclerosis.

Authors:  M KAYE; J E PRITCHARD; G W HALPENNY; W LIGHT
Journal:  Medicine (Baltimore)       Date:  1960-05       Impact factor: 1.889

3.  The calcium metabolism of a patient with renal insufficiency before and after partial parathyroidectomy.

Authors:  C RICH
Journal:  Metabolism       Date:  1957-11       Impact factor: 8.694

4.  The synthesis of [1,2-3H]vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat.

Authors:  P F Neville; H F DeLuca
Journal:  Biochemistry       Date:  1966-07       Impact factor: 3.162

5.  Uraemic bleeding: a reversible platelet defect corrected by dialysis.

Authors:  J H Stewart; P A Castaldi
Journal:  Q J Med       Date:  1967-07

6.  Vitamin D activity in normal human serum and serum proteins.

Authors:  P de Crousaz; B Blanc; I Antener
Journal:  Helv Odontol Acta       Date:  1965-10

7.  Alteration of hepatic protein synthesis in acute uremia.

Authors:  G J McCormick; L Shear; K G Barry
Journal:  Proc Soc Exp Biol Med       Date:  1966-05

8.  Subcellular location of vitamin D and its metabolites in intestinal mucosa after a 10-IU dose.

Authors:  S J Stohs; H F DeLuca
Journal:  Biochemistry       Date:  1967-11       Impact factor: 3.162

9.  VITAMIN D3: DIRECT ACTION ON THE SMALL INTESTINE OF THE RAT.

Authors:  D SCHACHTER; S KOWARSKI; J D FINKELSTEIN
Journal:  Science       Date:  1964-01-10       Impact factor: 47.728

10.  Studies of antiricketic activity in sera from patients with disorders of calcium metabolism and preliminary observations on the mode of transport of vitamin D in human serum.

Authors:  W C THOMAS; H G MORGAN; T B CONNOR; L HADDOCK; C E BILLS; J E HOWARD
Journal:  J Clin Invest       Date:  1959-07       Impact factor: 14.808

View more
  36 in total

1.  [The use of photon absorptiometry in renal osteodystrophy (author's transl)].

Authors:  A Samizadeh; H Loew; G Busch; H Müller; H Losse
Journal:  Klin Wochenschr       Date:  1977-10-15

2.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Authors:  W E Rutherford; P Bordier; P Marie; K Hruska; H Harter; A Greenwalt; J Blondin; J Haddad; N Bricker; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

3.  25-OH-Vitamin D in experimental and clinical uremia.

Authors:  H Schmidt-Gayk; E Ritz; O Mehls; J Goossen; P Förster
Journal:  Calcif Tissue Res       Date:  1977-05

Review 4.  Vitamin D metabolism. Recent advances.

Authors:  T C Stamp
Journal:  Arch Dis Child       Date:  1973-01       Impact factor: 3.791

5.  Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.

Authors:  R G Wong; A W Norman; C R Reddy; J W Coburn
Journal:  J Clin Invest       Date:  1972-05       Impact factor: 14.808

6.  Etiology of hyperparathyroidism and bone disease during chronic hemodialysis. I. Association of bone disease with potentially etiologic factors.

Authors:  A E Fournier; W J Johnson; D R Taves; J W Beabout; C D Arnaud; R S Goldsmith
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

7.  Chronic kidney disease and diabetes mellitus predict resistance to vitamin D replacement therapy.

Authors:  Hala M Alshayeb; Barry M Wall; Arif Showkat; L Darryl Quarles; Therese Mangold
Journal:  Am J Med Sci       Date:  2013-04       Impact factor: 2.378

8.  The transport of vitamin D in the serum of primates.

Authors:  R Bouillon; H van Baelen; P de Moor
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

9.  Effect of renal insufficiency on the active transport of calcium by the small intestine.

Authors:  R D Baerg; D V Kimberg; E Gershon
Journal:  J Clin Invest       Date:  1970-06       Impact factor: 14.808

Review 10.  Metabolic bone disease secondary to renal and intestinal disorders.

Authors:  F P Muldowney
Journal:  Calif Med       Date:  1969-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.